宜賓紙業(600793.SH):2021年度預盈2650萬元-2850萬元 同比扭虧
格隆匯1月20日丨宜賓紙業(600793.SH)公佈,經公司財務部門初步測算,預計2021年度歸屬於上市公司股東的淨利潤約為2650萬元到2850萬元之間;預計公司2021年度扣除非經常性損益的淨利潤約為2000萬元到2200萬元之間。
本期業績扭虧為盈的主要原因:
(一)2021年,公司積極開展“增產增收,節約節支”等活動,深挖內部潛力,優化內部組織管理結構,使公司成本和費用控制能力得到顯著提升。
(二)2021年,公司加強品牌建設,以市場為先導,積極拓寬銷售渠道,根據市場和客户變化調整生產模式和工藝技術,有效提升了公司產品的市場競爭力。,
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.